Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
View ORCID ProfileMorihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
doi: https://doi.org/10.1101/2020.06.03.20121020
Morihito Takita
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MD, PhDTomoko Matsumura
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MD, PhDKana Yamamoto
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
3Department of Reproductive, Developmental and Aging Sciences, Graduate School of Medicine, University of Tokyo, 4-6-1 Shirokanedai, Minato, Tokyo, 108-0071, Japan
MDErika Yamashita
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
Kazutaka Hosoda
4Department of Pediatrics, Navitas Clinic Tachikawa, Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
MDTamae Hamaki
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
MDEiji Kusumi
1Department of Internal Medicine, Navitas Clinic Tachikawa, 3-1-1 Shibasaki 4th floor of Ecute Tachikawa Bldg, Tachikawa, Tokyo, 190-0023, Japan
2Department of Internal Medicine, Navitas Clinic Shinjuku, 4-1-6 Shinjuku 7th floor of Newoman Bldg, Shinjuku, Tokyo, 160-0022, Japan
MDData Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request to protect the privacy of study participants.
Posted June 04, 2020.
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
Morihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
medRxiv 2020.06.03.20121020; doi: https://doi.org/10.1101/2020.06.03.20121020
Regional Difference in Seroprevalence of SARS-CoV-2 in Tokyo: Results from the community point-of-care antibody testing
Morihito Takita, Tomoko Matsumura, Kana Yamamoto, Erika Yamashita, Kazutaka Hosoda, Tamae Hamaki, Eiji Kusumi
medRxiv 2020.06.03.20121020; doi: https://doi.org/10.1101/2020.06.03.20121020
Subject Area
Subject Areas
- Addiction Medicine (325)
- Allergy and Immunology (641)
- Anesthesia (170)
- Cardiovascular Medicine (2438)
- Dermatology (208)
- Emergency Medicine (384)
- Epidemiology (11868)
- Forensic Medicine (10)
- Gastroenterology (707)
- Genetic and Genomic Medicine (3809)
- Geriatric Medicine (354)
- Health Economics (643)
- Health Informatics (2455)
- Health Policy (948)
- Hematology (348)
- HIV/AIDS (803)
- Medical Education (376)
- Medical Ethics (105)
- Nephrology (406)
- Neurology (3568)
- Nursing (201)
- Nutrition (534)
- Oncology (1854)
- Ophthalmology (542)
- Orthopedics (224)
- Otolaryngology (291)
- Pain Medicine (235)
- Palliative Medicine (68)
- Pathology (453)
- Pediatrics (1053)
- Primary Care Research (426)
- Public and Global Health (6237)
- Radiology and Imaging (1311)
- Respiratory Medicine (841)
- Rheumatology (386)
- Sports Medicine (329)
- Surgery (413)
- Toxicology (51)
- Transplantation (174)
- Urology (148)